CB Insights Blog AI’s moment in preclinical drug development arrives: Why formulation tech is the next frontier

This is the second report in a 3-part series on how AI is reshaping discovery, preclinical, and clinical research in drug R&D. Read part 1 on the discovery phase here. For pharma companies, it’s critical to maximize efficiency in preclinical … The post AI’s moment in preclinical drug development arrives: Why formulation tech is the next frontier appeared first on CB Insights Research.